SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion 
Rubio Directs U.S. Diplomats to Use X and Military Psyops to Counter Foreign Propaganda 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
Makemation: a Nollywood movie that shows AI in action in Africa 
Meta and Google just lost a landmark social media addiction case. A tech law expert explains the fallout 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
California's AI Executive Order Pushes Responsible Tech Use in State Contracts 
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Apple Turns 50: From Garage Startup to AI Crossroads 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
Facebook Founder Mark Zuckerberg and wife Priscilla Chan recently acquired the artificial intelligence startup called Meta for their charity group, the Chan Zuckerberg Initiative. The couple also has plans to make it free in the future so that scientists could have access to the technology produced by the company without having to pay.
Meta is an AI startup that largely focuses on developing machine data analytics for sifting through mountains of medical research papers, Fortune reports. The implications of such a technology for boosting the ability of medical professionals to get data on the latest findings is staggering, which is exactly why the Zuckerberg and Chan decided to get the startup.
This isn’t the only company that’s betting on the ability of AIs to significantly reduce the amount of time to process and presents information to researchers either. IBM and Watson are also invested in the field because they believe, as does the Chan Zuckerberg Initiative that advanced machine analytics is where the future of research is at.
In a blog post that Meta’s CEO Sam Molyneux wrote about the development, he noted how becoming part of the charity organization will significantly boost their interaction and options for contact with medical professionals than when it was just a startup. Considering what the company was trying to achieve in the first place, this is exactly in line with what it was going for.
“Through open solicitations, convenings, joint projects and grants, we will embrace the ideas and efforts of researchers in the diverse fields that Meta intersects with – including machine learning, network science, ontologies, science metrics, and data visualization,” the post reads.
After several months of refining the technology, the organization also plans on making it freely accessible to researchers, TechCrunch reports. Meta’s prospects basically revolve around removing some of the biggest obstacles in scientific advancements, which are money and digesting an insurmountable amount of data.
